SPOTLIGHT -
November 19th 2024
As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.
November 15th 2024
Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.
November 14th 2024
Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.
Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.
November 13th 2024
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
FDA Approves Fourth Biosimilar
September 26, 2016
Tufts CSDD Releases Findings from Diabetes Study
EpiPen Controversy: Mylan CEO Faces Congressional Committee
September 22, 2016
EMA Determines Certain Drugs Safe from Zika Contamination
Australian Pharma Market Set for "Modest Growth" to 2020
Eleven Biotherapeutics Acquires Canada's Viventia Bio
September 21, 2016
Australia Plans to Expedite Drug Approval Process
September 20, 2016
Osteoarthritis Market "to Treble by 2024"
New GSK Chief "Most Powerful Woman in FTSE 100"
EMA Blocks Imports from US's Pharmaceutics International
September 19, 2016
NICE Sets Out Proposed Technology Assessment Fees
Leela Barham looks at the potential cost to industry of the National Institute for Health and Care Excellence's plans to charge for TAs.
FDA Director Responds to Drug Pricing Concerns
September 16, 2016
EFPIA Calls for Urgent Action on Antimicrobial Resistance
September 15, 2016
Sanofi Appoints New North America CSO
September 14, 2016
Merck Announces 2016 Grant for Growth Innovation Winners
New Report Optimistic for Ophthalmology Treatment Market
Pfizer Taps Harvard's Ole Isacson as CSO of Neuroscience Research Unit
September 12, 2016
Biosimilars Face Repercussions of Drug Pricing Debate
HHS Awards $8.2 Million to Moderna for Zika Vaccine Development
September 9, 2016
Report Highlights Opportunity for Pharma Holograms, Says Trade Body
September 7, 2016
New Global Head of Development for Daiichi Sankyo
ADHD Market to Reach $13.9 Billion by 2024
EFPIA Pledges Continued Support for TTIP
"This once-in-a-generation opportunity must not be missed," say European trade associations.
Allergan Acquires RetroSense Therapeutics
September 6, 2016
New CFOs for Cipher and Nuvo
EFPIA's Richard Bergström Quits
September 1, 2016
Growing Philippines Market "Offers Investment Opportunities"
CPhI’s Pre-Connect Congress Outlines Pharma Trends
August 31, 2016
IMS and Quintiles Announce Post-Merger Leadership Team
August 30, 2016